Mar. 20, 2012—A genetic variation that causes early disruptions in serotonin signaling in the brain may contribute to autism spectrum disorder and other enduring effects on behavior.
Mar. 9, 2012—With the addition of a new 18,000-square-foot laboratory to be located within the Cool Springs Life Sciences Center, Vanderbilt University is expanding its research enterprise into Williamson County.
Mar. 9, 2012—Some patients may need a combo of medications to combat a condition that causes dizziness.
Feb. 3, 2012—Vanderbilt researcher and Gabon, Africa, native is working to discover ways to kill malaria-spreading mosquitoes.
Jan. 20, 2012—A strain of mutant mice provide a novel model for studying glucose intolerance and gestational diabetes during pregnancy and suggest that certain molecules may be useful for therapeutic applications.
Dec. 14, 2011—Fourteen Vanderbilt researchers have been elected fellows of the American Association for the Advancement of Science (AAAS).
Dec. 8, 2011—Compounds developed at Vanderbilt could offer a whole new way to treat atherosclerosis.
Dec. 1, 2011—Structural biology studies of a bacterial protein suggest a new target for treating life-threatening heart infection.
Oct. 28, 2011—Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.
Oct. 21, 2011—Bipolar depression and schizophrenia share patterns of changes in neurons that regulate information flow, new research shows.
Sep. 22, 2011—The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia.
Sep. 15, 2011—Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.